Auracare · In development

The decision support that stays out of the way.

Auracare is our clinical product: decision support that works during the appointment, not after it. The twin you may already know walks into the clinic with the patient, and the clinician keeps their attention exactly where it belongs.

Why now

Clinicians already want AI. Today’s tools don’t fit the room.

The appetite is settled; the fit isn’t. The tools on offer weren’t designed for the consultation, and it shows in three ways.

~80% of doctors already reach for AI

The demand is already there

Clinicians want the help. What breaks is the moment they turn to a screen mid-consultation: the patient watches their doctor google, and trust quietly erodes.

34% specialty-benchmark score

Generic by architecture

The general-purpose models these tools run on score around a third on specialty-level clinical benchmarks, with no personalisation to the patient actually in the room.

gaps between every record

Disconnected from daily life

The record is a series of snapshots with long silences in between. Lifestyle and social history are slow to gather and easy to misremember, so the picture is always partial.

Inside the consultation

Everything arrives automatically, so nothing interrupts.

Auracare is built around a single rule: the moment a clinician has to break away to search, type or look something up is the moment the consultation suffers. So it removes those moments.

  1. Nobody stops to type

    The consultation is transcribed as it happens. No one breaks the conversation to write notes, and no one reads from a keyboard.

  2. The context is already in the room

    The patient arrives with a complete lifestyle summary from their twin, and acute vitals stream live from our own devices, so nothing has to be dug up on the spot.

  3. The clinician stays with the patient

    Auracare reasons quietly in the background and surfaces what’s useful. The clinician never appears to search anything, so eye contact, and the relationship, holds.

Our hardware, straight into the core

A closed link, with no middleman.

Acute readings don’t get typed in or pulled from someone else’s integration. Our own devices feed the reasoning core directly: one closed hardware-to-software link, so the data the core sees is exactly the data the device captured.

  • Recording stethoscope

    Captures heart and lung sounds as data the core can read, not just for the ear.

  • Blood-pressure monitor

    Clinical-grade readings, streamed straight into the reasoning core.

  • Otoscope

    A closer look inside, captured and passed on to the core automatically.

And more devices are on the way, the same closed hardware-to-software link, extended to new measurements.

What comes back

Three outputs. One decision, and it’s the clinician’s.

The core doesn’t hand down an answer. It lays out what it has reasoned toward, ranked and traceable, and leaves the judgement where it has to stay: with the person in the room.

  • Ranked differentials

    Possible diagnoses ordered by likelihood, laid out for the clinician to weigh. The call is always theirs to make.

  • Next steps, tailored

    Guideline-aligned options that respect what’s available where the clinician works, including that practice’s own referral rules.

  • Documentation, automatic

    Structured, formatted consultation notes written by the core, so admin shrinks and screen time turns back into patient time.

Illustrative, not a real patient Ranked differential

The figure beside each is clinician agreement, not model certainty: how often clinicians agreed with that placement in live studies on the shipped core.

  • Viral upper-respiratory infection 61%
  • Acute bacterial sinusitis 22%
  • Allergic rhinitis 11%

Read it as: when the core leads with viral URTI, clinicians agree 61% of the time, a rate we measure on the live product and keep measuring. The core never reports a probability of being right. The clinician selects, and that selection shapes the next steps and the notes.

How it reaches the clinic

Two clean paths, one product.

We’re deliberately not tying Auracare to a single route to market. Both keep the clinician’s experience the same; they differ only in who pays.

Path A

Free to the clinician

Funded on the pharmaceutical side and left free for clinicians: the model that has already proven clinicians will adopt tools built for them.

Path B

Direct to providers

Sold to healthcare providers on the strength of the clinician time it saves, measured in shorter admin and fewer unnecessary referrals.

Auracare is our clinical decision support system, still in development. Its regulatory pathway is not yet confirmed and is under active, continuous review.

Building the clinical side? Let’s talk.

Clinical partners, health systems and investors: we’d like to hear from you as Auracare moves toward its first trials.